CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-Macrophages
Share this article Share this article Allogeneic macrophage therapies may prove successful in providing a solution forged in cell therapy to a broader population of patients, further extending the potential benefits of CARISMA's CAR-Macrophage (CAR-M) platform beyond oncology and into other disease states with unmet clinical needs. "The collaboration with Dr. Blazar marks the initiation of the development of allogeneic, universal donor derived monocyte and macrophage cell therapies at CARISMA," said Michael Klichinsky, PharmD, PhD, Scientific Co-Founder and Senior Vice President of Researc...
Source: prnewswire.com